Immunotherapy for Food Allergy: Are We There Yet?

Area of Science:

• Allergy and Immunology
• Clinical Therapeutics
• Food Science

Background:

• Current clinical research explores food allergen-specific immunotherapy via oral (OIT), sublingual (SLIT), and epicutaneous (EPIT) routes.
• Immunotherapy aims to induce desensitization (temporary hyporesponsiveness) and tolerance (symptom-free ingestion after avoidance).
• While OIT achieves desensitization in most patients, tolerance is achieved by a minority.

Purpose of the Study:

• To review current allergen-specific immunotherapy strategies for food allergy treatment.
• To discuss the efficacy, safety, and dosing of OIT, SLIT, and EPIT.
• To explore novel strategies for improving immunotherapy safety and efficacy.

Main Methods:

• Review of current clinical research on food allergen-specific immunotherapy.
• Comparison of OIT, SLIT, and EPIT routes regarding maintenance doses, efficacy, and adverse events.
• Discussion of combined OIT and anti-IgE therapy, early OIT initiation, and modified allergen strategies.

Main Results:

• OIT involves higher maintenance doses than SLIT and EPIT.
• OIT demonstrates higher efficacy than SLIT but with a greater rate of systemic adverse events.
• Early initiation of peanut OIT in infants and young children may offer improved efficacy and safety.

Conclusions:

• Food allergen immunotherapy, particularly OIT, shows promise but requires further research to optimize safety and efficacy.
• Modifications in allergen structure and the addition of immunomodulatory adjuvants are potential avenues for enhancement.
• Early intervention and route-specific considerations are crucial for successful food allergy treatment.